Close Menu

NEW YORK – Genetron Health announced Thursday a strategic partnership with Thermo Fisher Scientific to commercialize next-generation sequencing-based diagnostics in China.

The deal will bring the Genetron S5, which is based on Thermo Fisher's Ion GeneStudio S5 instrument for targeted NGS, to China's public hospitals for use in cancer diagnostics, genetic disease diagnosis, microbial testing, and reproductive health testing, among other uses.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.